Inspire Medical Systems (INSP) Research & Development (2017 - 2026)

Inspire Medical Systems has disclosed Research & Development across 10 years of filings, most recently posting $25.8 million for Q1 2026.

• Research & Development for Q1 2026 came in at $25.8 million, down 7.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $101.2 million (down 10.52% YoY), and the FY2025 annual result was $103.2 million, down 9.61% from the prior year.
• Research & Development came in at $25.8 million for Q1 2026 at Inspire Medical Systems, up from $24.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $31.1 million in Q4 2023 to a low of $11.9 million in Q1 2022.
• The 5-year median for Research & Development is $26.1 million (2024), against an average of $25.2 million.
• Across the five-year window, Research & Development jumped 118.36% in 2022 and dropped 17.78% in 2025, its largest moves.
• Inspire Medical Systems' Research & Development stood at $21.2 million in 2022, then jumped by 46.14% to $31.1 million in 2023, then declined by 2.31% to $30.3 million in 2024, then slipped by 17.78% to $24.9 million in 2025, then advanced by 3.54% to $25.8 million in 2026.
• The last three Research & Development figures came in at $25.8 million (Q1 2026), $24.9 million (Q4 2025), and $24.2 million (Q3 2025), per Business Quant data.